Periodic fever syndromes, autoinflammatory diseases, Still’s disease and MAS/HLH
Andrea Doria, MD, PhD, MSc, MBA
The Hospital for Sick Children
Toronto, ON, Canada
Disclosure(s): Baxalta-Shire: Grant/Research Support (Ongoing); Novo Nordisk: Grant/Research Support (Ongoing); Terry Fox Foundation: Grant/Research Support (Ongoing)
Polly Ferguson, MD
University of Iowa Carver College of Medicine
Iowa City, IA, United States
Disclosure(s): No financial relationships with ineligible companies to disclose
Christian Hedrich, MD, PhD
University of Liverpool
Liverpool, United Kingdom
Disclosure(s): Novartis: Consultant (Terminated, August 31, 2021)
Pediatric rheumatologists are increasingly called to manage patients with chronic non-bacterial oteomyelitis (CNO), a rare disease now being recognized in many children. As a rare disease, there is little formal research evidence to inform its management. This session will review the state of the art in the management of CNO, to raise awareness of the expanded spectrum of clinical presentation, imaging, and treatments in use.
Speaker: Polly Ferguson, MD – University of Iowa Carver College of Medicine
Speaker: Andrea Doria, MD, PhD, MSc, MBA – The Hospital for Sick Children
Speaker: Christian Hedrich, MD, PhD – University of Liverpool
